Navigation Links
Niutang Sucralose Patent Litigation Successfully Concluded
Date:6/1/2009

Tate & Lyle will not appeal ITC decision; Voluntarily dismisses District Court case

BREA, Calif., June 1 /PRNewswire/ -- Changzhou Niutang, one of the largest global manufacturers of sucralose, and its U.S. subsidiary, US Niutang, today announced that Tate & Lyle will not appeal the recent decision made by the U.S. International Trade Commission that decisively rejected Tate & Lyle's infringement allegations against Niutang. In addition, Tate & Lyle has requested a voluntary dismissal of the patent infringement allegations it brought against Niutang in the United States District Court.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090528/CG23830LOGO)

"We are delighted to have all aspects of this litigation successfully concluded, with a complete victory in favor of Niutang," said Licheng Wang Jr., General Manager of Changzhou Niutang. "We will continue to focus our attention on what we do best - providing the highest quality sweeteners and food additives along with outstanding service to our worldwide customers."

Niutang has steadily grown its sucralose customer base, which now spans North America, Central America, South America, Europe and Asia. Niutang is already one of the largest manufacturers of aspartame in the world, and it has built upon that successful track record in growing its sucralose business.

"Niutang's sucralose sales have more than tripled from 2007 to 2008," continued Wang. "We recently completed the expansion of our sucralose capacity to 300 metric tons and have announced our plans to increase our capacity to 500 metric tons by 2012. As our sucralose business continues to grow, we remain committed to providing our customers with the high-quality products and unsurpassed level of customer service they have come to expect from Niutang."

Niutang is one of the largest and most experienced global manufacturers of sucralose. The company's established track record is built upon the highest standards of quality control, with products that are:

  • Manufactured according to cGMP requirements as stated in CFR 21 Part 110
  • Produced to meet all quality specifications required by current FCC
  • Moody International ISO 9001:2000/cGMP/HACCP certified
  • Kosher and Halal certified
  • Registered with the U.S. FDA in accordance with the Security and Bioterrorism Preparedness and Response Act of 2002

About Niutang

Niutang Chemical is one of the world's leading manufacturers and distributors of food additives, chemicals and pharmaceutical intermediates that are instrumental to food, beverage, pharmaceutical, nutraceutical and industrial products. Established in 1969, Niutang's commitment to producing the highest quality food additives at competitive prices has ensured its rapid growth into a leading global manufacturer of aspartame, folic acid, and more recently, sucralose. The company is certified in meeting the most stringent U.S. and European manufacturing, compliance and quality benchmarks. Based in China, Niutang also has sales and quality control operations in the United States and Europe that support its strong reputation for integrity and customer service. The company's website is www.niutang.com. For inquiries regarding Niutang Sucralose sales, please contact sales@niutang.us.

    For more information:

    Doreen Lubeck
    DJ Lubeck, LLC
    773-583-4331
    djlubeck@yahoo.com


'/>"/>
SOURCE Niutang Chemical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Niutang to Expand Sucralose Capacity 66 Percent by 2012
2. Niutang Recruits Seasoned Executive to Open U.K. Office
3. GDFII/L&P Sucralose Win Over Competitor Tate & Lyle
4. SENOMYX RECEIVES GENERALLY RECOGNIZED AS SAFE (GRAS) DETERMINATION FOR S2383 SUCRALOSE ENHANCER
5. Falcon Genomics Awarded Patent for Innovative Cancer Test
6. Viral Genetics Has Option Under Issued Key Patent for Cancer Drug
7. CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS)
8. Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
9. Appeal Proceedings on European VisionBlue Patent Stayed; Patent Remains in Force
10. Intradigm Announces Issuance of RNA Interference (RNAi) Patent Covering Potent siRNA Sequence
11. Palomar Wins Two European Hair Removal Patent Opposition Hearings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... , ... A product of digesting a micronutrient found in soy may hold ... soy foods, while others do not, a University of Pittsburgh Graduate School of Public ... made by some types of “good” gut bacteria when they metabolize isoflavones (micronutrients found ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Pet obesity in ... 54% of dogs, according to the Association for Pet Obesity Prevention (APOP). During the ... pet food issues such as the benefits of corn and grains, value of raw ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... Safety, patient advocates stress that the patient context (age, illness and life choices) ... reasons to mitigate their occurrence. In addition, all too often, studies ...
(Date:2/21/2017)... Okla. (PRWEB) , ... February 21, 2017 , ... ... new Choctaw Nation Regional Medical Clinic in Durant, Oklahoma, on Feb. 21. , ... by clinic tours for community members, clinic employees, the construction team and tribal ...
(Date:2/21/2017)... ... ... Individuals who have been diagnosed with cancer are at ... management. Regular exercise in proper environments has been shown to benefit these patients, ... 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx webinar led by ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Conn. , Feb. 22, 2017   Protein ... maker of Flublok® Influenza Vaccine , announced today ... Partnership for Influenza Vaccine Introduction (PIVI) and the Mongolian ... devastating impacts of the flu.  The doses of Flublok ... Mongolia for health care workers, ...
(Date:2/22/2017)... , Feb. 22, 2017  Tri-Source Pharma announced ... efforts. A series of newly appointed positions were added ... and CEO, Robert DiCrisci , in the implementation ... and management of the recently consolidated subsidiary companies. ... executive team will be composed of the following eight ...
(Date:2/22/2017)... , February 22, 2017 ... Composite, the Dow Jones Industrial Average, and the ... Seven out of nine sectors ended Tuesday,s trading ... market sentiment, Stock-Callers.com assessed the following Medical Instruments ... Inc. (NASDAQ: TNDM), C. R. Bard Inc. (NYSE: ...
Breaking Medicine Technology: